Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

More research is needed before using brown fat to treat polycystic ovary syndrome.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Flavonoids in Iraqi marshland plants have potential health benefits like antioxidant and anti-inflammatory effects.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Addressing underrepresentation in Parkinson's research is crucial for better treatments and understanding.

Finasteride may improve prostate cancer treatment outcomes.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Early treatment of traction alopecia can reverse hair loss; prevention involves avoiding tight hairstyles.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.